PHARMA quarterly results — PHARMANIAGA BERHAD
PHARMANIAGA BERHAD (7081) quarterly revenue, net profit, EPS and dividends from Bursa Malaysia filings.
PHARMA company announcements · All KLSE quarterly results
| Quarter ended | Quarter | Revenue (RM'000) | Net profit (RM'000) | EPS (sen) | Dividend (sen) | YoY |
|---|---|---|---|---|---|---|
| 2026-06-30 | Q2 | 1,041,034 | 12,493 | 0.95 | 0.48 | +215.5% |
| 2026-03-31 | Q1 | 1,178,524 | 31,471 | 0.48 | 0.25 | +6.4% |
| 2025-12-31 | Q4 | 938,277 | 7,695 | 0.21 | — | +227.9% |
| 2025-09-30 | Q3 | 1,007,263 | 7,276 | 0.28 | — | -92.8% |
| 31 mar 2025 | Q1 | 1,055,349 | 29,579 | 2.05 | 0 | +15.0% |
| 31 dec 2024 | Q4 | 926,442 | 2,347 | 0.16 | 0 | +107.0% |
| 30 sep 2024 | Q3 | 1,029,822 | 101,032 | 7.01 | 0 | +305.0% |
| 30 jun 2024 | Q2 | 838,256 | 2,797 | 0.19 | 0 | +43.0% |
| 31 mar 2024 | Q1 | 964,959 | 25,646 | 1.78 | 0 | +869.0% |
| 30 sep 2023 | Q3 | 885,486 | -49,339 | -3.67 | 0 | -253.0% |
| 30 jun 2023 | Q2 | 848,734 | 1,961 | 0.15 | 0 | +172.0% |
| 30 jun 2022 | Q2 | 761,102 | 722 | 0.06 | 0.5 | -95.0% |